<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-14T11:47:14Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.17184" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.17184</identifier>
    <datestamp>2024-03-20T10:02:14Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2024-03-20</dc:date>
  <dc:title>RNA SEQ data of mouse AMs and MF treated with LC in vivo</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.17184</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>AMs and EGFP+-MF derived from fibrotic mouse lung tissues in vivo and divided into the following two groups.: 1. The control group was treated with solvent (water); 2. Lithium carbonate group was treated with 75 mg/kg lithium carbonate for 3/10 days. The mouse model of reversible PF was generated by single intratracheal instillation of BLM (3U/kg) in 50 &amp;micro;L of H2O; For therapeutic experiments, mice were i.g. injected with the indicated agents every day beginning at day 14 after BLM challenge for 10 days. AMs were obtained from BALF,&amp;nbsp;EGFP+-MF derived from fibrotic Acta2-EGFP mice. The samples were lysed with Trizol and then total RNA was extracted for RNASEQ sequencing.&amp;nbsp;&amp;nbsp;Sample B1, B5, B7 was CTR in the control group (AMs); Sample LC2, LC3, LC7 was LC in LC treatment group (AMs). Sample C1, C3, C4 was CTR in the control group (MF); Sample T1, T2, T3 was LC in LC treatment group (MF).</dc:description>
  <dc:subject>MOUSE ;  lithium carbonate; Pulmonary fibrosis; myofibroblasts; macrophages</dc:subject>
  <dc:creator>位珂珂</dc:creator>
  <dc:creator>Bo Huang</dc:creator>
  <dc:creator>马婧薇</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>